Moving beyond COVID: mRNA Steps into CAR T cell therapy for Myasthenia Gravis

By: Paige Bond Movement requires communication between both muscles and nerves. At the neuromuscular junction (Figure 1), nerves release a chemical messenger, acetylcholine, which binds to specific receptors on muscle cells to trigger muscle contraction. Disrupting the activity of the acetylcholine receptors can lead to muscle weakness or the inability to voluntarily contract muscles at … Continue reading Moving beyond COVID: mRNA Steps into CAR T cell therapy for Myasthenia Gravis